Ongoing epidemic of cutaneous leishmaniasis among Syrian refugees, Lebanon

Emerging Infectious Diseases

Volumn 20, Issue 10, 2014, Pages 1712-1715

  Saroufim, Maya ^a   Charafeddine, Khalil ^a   Issa, Grace ^a   Khalifeh, Haifaa ^a   Habib, Robert H ^a   Berry, Atika ^b   Ghosn, Nada ^b   Rady, Alissar ^c   Khalifeh, Ibrahim ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b MINISTRY OF PUBLIC HEALTH   (Lebanon)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CREATININE; MEGULAMINE ANTIMONATE; UNCLASSIFIED DRUG; MEGLUMINE; MEGLUMINE ANTIMONIATE; ORGANOMETALLIC COMPOUND;

ADOLESCENT; ARTICLE; BLOOD CELL COUNT; CHILD; ELECTROCARDIOGRAPHY; EPIDEMIC; HEAD; HUMAN; HUMAN TISSUE; INSECT BITE; LEISHMANIA MAJOR; LEISHMANIA TROPICA; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MIGRATION; NECK; PAPULAR RASH; POLYMERASE CHAIN REACTION; PUNCH BIOPSY; REFUGEE CAMP; SENSORY ORGAN INFLAMMATION; SKIN DEFECT; SKIN LEISHMANIASIS; SYRIAN ARAB REPUBLIC; FEMALE; INFANT; LEBANON; LEISHMANIASIS, CUTANEOUS; MALE; PATHOLOGY; PRESCHOOL CHILD; REFUGEE; YOUNG ADULT;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; LEBANON; LEISHMANIASIS, CUTANEOUS; MALE; MEGLUMINE; ORGANOMETALLIC COMPOUNDS; REFUGEES; SYRIA; YOUNG ADULT;

EID: 84907291516     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2010.140288     Document Type: Article

References (14)

1. United Nations High Commissioner for Refugees. 2014 Syria regional response plan. Strategic overview [cited 2013 Dec 16]. http://www.unhcr.org/syriarrp6
2. United Nations High Commissioner for Refugees. 2014 UNHCR country operations profile—Lebanon [cited 2014 Jun 27]. http://www. unhcr.org/cgi-bin/texis/vtx/page?page=49e486676&submit=GO
3. Murray HW, Berman JD, Davies CR, Saravia NG. Advances in leishmaniasis. Lancet. 2005;366:1561-77. http://dx.doi.org/10.1016/ S0140-6736(05)67629-5
4. World Health Organization. Manual for case management of cutaneous leishmaniasis. Geneva: The Organization; 2012.
5. Herwaldt BL. Leishmaniasis. Lancet. 1999;354:1191-9. http://dx. doi.org/10.1016/S0140-6736(98)10178-2
6. Buffet DP. Leishmaniasis: a guide for disease management. Paris: Sanofi Aventis; 2001.
7. Aoun K, Bouratbine A. Cutaneous leishmaniasis in North Africa: a review. Parasite. 2014;21:14. http://dx.doi.org/10.1051/parasite/ 2014014
8. Douba M, Mowakeh A, Wali A. Current status of cutaneous leishmaniasis in Aleppo, Syrian Arab Republic. Bull World Health Organ. 1997;75:253-9.
9. Yehia L, Adib-Houreih M, Raslan WF, Kibbi AG, Loya A, Firooz A, et al. Molecular diagnosis of cutaneous leishmaniasis and species identification: analysis of 122 biopsies with varied parasite index. J Cutan Pathol. 2012;39:347-55. http://dx.doi.org/10.1111/ j.1600-0560.2011.01861.x
10. Sina B, Kao GF, Deng AC, Gaspari AA. Skin biopsy for inflammatory and common neoplastic skin diseases: optimum time, best location and preferred techniques. A critical review. J Cutan Pathol. 2009;36:505-10. http://dx.doi.org/10.1111/j.1600-0560.2008.01175.x
11. Desjeux P. The increase in risk factors for leishmaniasis worldwide. Trans R Soc Trop Med Hyg. 2001;95:239-43. http://dx.doi. org/10.1016/S0035-9203(01)90223-8
12. Reithinger R, Mohsen M, Leslie T. Risk factors for anthroponotic cutaneous leishmaniasis at the household level in Kabul, Afghanistan. PLoS Negl Trop Dis. 2010;4:e639. http://dx.doi.org/10.1371/ journal.pntd.0000639
13. Alvar J, Velez ID, Bern C, Herrero M, Desjeux P, Cano J, et al. Leishmaniasis worldwide and global estimates of its incidence. PLoS ONE. 2012;7:e35671. http://dx.doi.org/10.1371/journal. pone.0035671
14. World Health Organization. The WHO Leishmaniasis Control Team news, Feb. 2013 [cited 2014 Apr 21]. http://www.who. int/en/